In just two weeks, the UFC will host its ambitious Freedom 250 event at the White House. Reportedly, between 4,000 and 5,000 ...
Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced that new 48-week data from the IMPACT Phase 2b ...
Researchers from Ben-Gurion University of the Negev, Leipzig and Harvard, say visceral fat reduction even for 18 months can ...
While losing more muscle than fat would be reflected as weight loss on a weighing scale, it is actually not a loss that is ...
Losing weight may involve rewiring the gut and the brain at the same time. In a study of obese adults, an intermittent fasting-style diet led to significant weight loss, healthier metabolic markers, ...
A groundbreaking long-term MRI study at Ben-Gurion University of the Negev (BGU) in Beersheba shows that lower accumulation of abdominal (visceral) fat is linked with a significant slowing of brain ...
India faces a silent health crisis where invisible abdominal fat, not visible weight, poses significant risks. This 'high ...
Altimmune announces IMPACT phase 2b data from pemvidutide; shows significant metabolic improvements in patients with MASH: Gaithersburg, Maryland Saturday, May 30, 2026, 16:00 Hrs ...
Aging is not sudden. It is the slow loss of muscle, bone, metabolic control, and cognitive clarity, long before disease is ...
Testosterone replacement therapy may improve body composition in men with low testosterone, according to research, but it isn’t a primary weight loss treatment.
Obesity is commonly diagnosed using BMI, but this approach has several limitations. Researchers at Lund University and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results